Form D · Other Health Care

ZIELBIO, INC.

Charlottesville, VA · CIK 0001521067

Offering snapshot reported Sep 27, 2022 · SEC filing

Reported sold
$7.5M
Offering amount: $20M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 13, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 27, 2022Initial$7,499,996No comparison3SEC filing
Sep 19, 2019Initial$10,999,998No comparison3SEC filing
Jun 16, 2017Amendment$754,996$304,996vs Jul 28, 201511SEC filing
Jul 28, 2015Amendment$450,000$340,000vs Nov 2, 20116SEC filing
Nov 2, 2011Amendment$110,000$60,000vs May 26, 20113SEC filing
May 26, 2011Initial$50,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-460003

Source: Form D, filed Sep 27, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jason Dinges Director
Meredith Fisher Director
Gregory B. Fralish Director, Executive
Anne Heldreth Executive
Kimberly A. Kelly Director, Executive
Colin B. Rolph Executive
Dieter Weinand Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1317 Carlton Avenue Suite 200
Charlottesville, VA, 22902